A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart Failure

This publication has 14 references indexed in Scilit:

• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
  European Heart Journal, 2012
• The Effects of Velvet Antler of Deer on Cardiac Functions of Rats with Heart Failure following Myocardial Infarction
  Evidence-Based Complementary and Alternative Medicine, 2012
• Qiliqiangxin Inhibits the Development of Cardiac Hypertrophy, Remodeling, and Dysfunction During 4 Weeks of Pressure Overload in Mice
  Journal of Cardiovascular Pharmacology, 2012
• Chinese Medicine Shenfu Injection for Heart Failure: A Systematic Review and Meta-Analysis
  Evidence-Based Complementary and Alternative Medicine, 2012
• 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
  JACC, 2009
• Qiliqiangxin regulates the balance between tumor necrosis factor-α and interleukin-10 and improves cardiac function in rats with myocardial infarction
  Cellular Immunology, 2009
• Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease
  Journal of the American Society of Nephrology, 2006
• N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients
  Circulation, 2004
• Prognostic Impact of Plasma N-Terminal Pro–Brain Natriuretic Peptide in Severe Chronic Congestive Heart Failure
  Circulation, 2004
• Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment
  Clinical Endocrinology, 1997